Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 05, 2015 9:00 AM ET

Capital Markets

Company Overview of Versant Ventures, Inc.

Company Overview

Versant Ventures is a venture capital firm specializing in incubation, seed, start-ups, and early stage investments. It seeks to invest in all segments of healthcare including, medical devices and diagnostics; med-tech; life sciences that include biopharmaceuticals and biotechnology platforms; healthcare services; and healthcare information technology. The firm prefers to invest in companies based in the United States and Western Europe. The firm seeks to invest in the biotechnology sector in Canada. The firm typically invests between $10 million and $20 million into each startup before it’s sold or goes public. It will not invest in a company unless it has at least $500 million in annualize...

3000 Sand Hill Road

Building 4

Suite 210

Menlo Park, CA 94025

United States

Founded in 1999

Phone:

650-233-7877

Fax:

650-854-9513

Key Executives for Versant Ventures, Inc.

Managing Director
Managing Director
Age: 59
Managing Director
Co-founder and Managing Director
Age: 61
Co-Founder and Managing Director
Age: 67
Compensation as of Fiscal Year 2014.

Versant Ventures, Inc. Key Developments

Versant Ventures, Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 12:00 PM

Versant Ventures, Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 12:00 PM. Venue: Sheraton Centre Toronto Hotel (Corner of York and Queen St. West), Toronto, Ontario, M5H 3M9, Canada. Speakers: Jerel C. Davis, Partner.

Versant Ventures Seeks Acquisitions

Versant Ventures, Inc. is looking for acquisition opportunities. The Versant V portfolio will be diversified with investments made across the healthcare sector and at all stages of company development. Consistent with recent strategy, a primary focus will be the discovery and development of novel therapeutics. Many of these companies will be launched by Versant and will enter into “build-to-buy” structured acquisitions with strategic partners at the outset.

Versant Ventures, Inc. Presents at Emerging Medical Technologies Summit, Nov-11-2014 03:00 PM

Versant Ventures, Inc. Presents at Emerging Medical Technologies Summit, Nov-11-2014 03:00 PM. Venue: Sofitel Hotel San Francisco, 223 Twin Dolphin Dr., Redwood City, CA 94065, United States. Speakers: Charles M. Warden, Managing Director.

Similar Private Companies By Industry

Company Name Region
Deucalion Advisors, LLC United States
Farmland Securities Company United States
Gerson Global Advisors United States
ETB Holdings, Inc. Capital Trust XX United States
Stonepine Advisors, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 28, 2015
CRISPR Therapeutics AG
Merger/Acquisition
April 27, 2015
Quanticel Pharmaceuticals, Inc.
Private Placement
February 3, 2015
Laguna Pharmaceuticals Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Versant Ventures, Inc., please visit www.versantventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.